Cargando…

Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves’ Ophthalmopathy

Graves’ ophthalmopathy (GO) is a disfiguring and sometimes blinding disease, which is characterized by inflammation and swelling of orbital tissues, with fibrosis and adipogenesis being predominant features. The aim of this study is to investigate whether the expression levels of fibrosis-related ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Chieh-Chih, Wu, Shi-Bei, Chang, Pei-Chen, Wei, Yau-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657967/ https://www.ncbi.nlm.nih.gov/pubmed/26599235 http://dx.doi.org/10.1371/journal.pone.0143514

Ejemplares similares

Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves’ orbital fibroblasts
por: Tsai, Chieh-Chih, et al.
Publicado: (2018)

Increased response to oxidative stress challenge in Graves’ ophthalmopathy orbital fibroblasts
por: Tsai, Chieh-Chih, et al.
Publicado: (2011)

The protective effect of antioxidants on orbital fibroblasts from patients with Graves’ ophthalmopathy in response to oxidative stress
por: Tsai, Chieh-Chih, et al.
Publicado: (2013)

Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy
por: Kau, Hui-Chuan, et al.
Publicado: (2016)

Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves’ Ophthalmopathy
por: Wu, Shi-Bei, et al.
Publicado: (2021)

Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy
por: Xiong, Haibo, et al.
Publicado: (2018)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves’ Ophthalmopathy
por: Virakul, Sita, et al.
Publicado: (2021)

The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves’ Ophthalmopathy
por: Hou, Tzu-Yu, et al.
Publicado: (2021)

RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2021)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Adiponectin concentration in the orbital fat of patients with Graves’ ophthalmopathy
por: Soiberman, Uri, et al.
Publicado: (2013)

Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects
por: Li, Haoyu, et al.
Publicado: (2020)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Functionally enhanced placenta-derived mesenchymal stem cells inhibit adipogenesis in orbital fibroblasts with Graves’ ophthalmopathy
por: Kim, Jae Yeon, et al.
Publicado: (2020)

JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves’ Orbital Fibroblasts
por: Hou, Tzu-Yu, et al.
Publicado: (2021)

Changes in Choroidal Perfusion after Orbital Decompression Surgery for Graves' Ophthalmopathy
por: Nik, Narieman, et al.
Publicado: (2017)

MicroRNA-146a downregulates the production of hyaluronic acid and collagen I in Graves' ophthalmopathy orbital fibroblasts
por: Liu, Wei, et al.
Publicado: (2020)

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves’ ophthalmopathy patients
por: Shahida, B, et al.
Publicado: (2019)

Graves’ ophthalmopathy: low-dose dexamethasone reduces retinoic acid receptor-alpha gene expression in orbital fibroblasts
por: Cury, Sarah Santiloni, et al.
Publicado: (2018)

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Comparative assessment of Graves’ disease and main extrathyroidal manifestation, Graves’ ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue
por: Ji, Dong Yoon, et al.
Publicado: (2018)

Use of Rituximab After Orbital Decompression Surgery in Two Grave’s Ophthalmopathy Patients Progressing to Optic Neuropathy
por: Zhang, Benping, et al.
Publicado: (2020)

Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves’ disease and Graves’ ophthalmopathy
por: Tsai, Kun-Hsi, et al.
Publicado: (2012)

Inhibitory Effects of α-Lipoic Acid on Oxidative Stress-Induced Adipogenesis in Orbital Fibroblasts From Patients With Graves Ophthalmopathy
por: Hwang, Sena, et al.
Publicado: (2016)

Peripheral primitive neuroectodermal tumor of the orbit in Graves’ ophthalmopathy – A rare presentation
por: Stephen, Mary A., et al.
Publicado: (2023)

FRI547 Orbital Surgery In Moderate-To-Severe Graves´Ophthalmopathy: Institutional Experience
por: Delfino, Laura, et al.
Publicado: (2023)

Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy
por: Zhang, Xin, et al.
Publicado: (2023)

Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts
por: Diao, Jiale, et al.
Publicado: (2022)

Immunological Aspects of Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2019)

Simvastatin Inhibits CYR61 Expression in Orbital Fibroblasts in Graves' Ophthalmopathy through the Regulation of FoxO3a Signaling
por: Wei, Yi-Hsuan, et al.
Publicado: (2021)

Transcaruncular Medial Wall Orbital Decompression: An Effective Approach for Patients with Unilateral Graves Ophthalmopathy
por: Hill, Robert H., et al.
Publicado: (2012)

Balancing orbital volume reduction and redistribution for a tailored surgical treatment in Graves’ ophthalmopathy
por: Costan, Victor Vlad, et al.
Publicado: (2020)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Integrative metabolic analysis of orbital adipose/connective tissue in patients with thyroid-associated ophthalmopathy
por: Huang, Jiancheng, et al.
Publicado: (2022)

Original endoscopic orbital decompression of lateral wall through hairline approach for Graves’ ophthalmopathy: an innovation of balanced orbital decompression
por: Gong, Yi, et al.
Publicado: (2018)

Orbital positron emission tomography/computed tomography (PET/CT) imaging findings in graves ophthalmopathy
por: García-Rojas, Leonardo, et al.
Publicado: (2013)

Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves' Ophthalmopathy
por: Xu, Lingling, et al.
Publicado: (2017)

The Synergistic Effect of Corticosteroids and Mycophenolic Acid on Chemokines in Orbital Cells From Patients With Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4kq814enrndcpknq153ak64qs6